
Corporate Action23 Oct 2026, 12:02 pm
Medicamen Biotech Allots 5 Lakh Shares on Warrant Conversion
AI Summary
Medicamen Biotech Limited's Preferential Issue Committee approved the allotment of 5,00,000 Equity Shares upon conversion of 5,00,000 Fully Convertible Warrants. The shares were issued at Rs. 530/- each, raising an aggregate of Rs. 26,50,00,000/- (₹26.50 Crore) in cash. The allotment was made on a preferential basis to Shivalik Rasayan Limited, an entity belonging to the 'Promoter and Promoter Group' category. This allotment increases the company's paid-up equity share capital to Rs. 14,06,28,150/-, comprising 1,40,62,815 equity shares of face value Rs. 10/- each.
Key Highlights
- Allotment of 5,00,000 equity shares from warrant conversion.
- Raised ₹26.50 Crore via preferential issue.
- Allotted to Promoter Group entity, Shivalik Rasayan Limited.
- Paid-up equity share capital increased post-allotment.
Price Impact
More from MEDICAMEQ